Published in Int J Clin Oncol on August 15, 2008
Epidemiology and natural history of central venous access device use and infusion pump function in the NO16966 trial. Br J Cancer (2014) 0.81
Arm port implantation in cancer patients. Int J Clin Oncol (2010) 0.80
The central vein access port and catheter in outpatient chemotherapy for colorectal cancer: a retrospective study of 101 patients. Surg Today (2011) 0.79
Totally implantable venous power ports of the forearm and the chest: initial clinical experience with port devices approved for high-pressure injections. Br J Radiol (2012) 0.77
Short-term and long-term outcome of radiological-guided insertion of central venous access port devices implanted at the forearm: a retrospective monocenter analysis in 1704 patients. Eur Radiol (2014) 0.76
Upper arm central venous port implantation: a 6-year single institutional retrospective analysis and pictorial essay of procedures for insertion. PLoS One (2014) 0.75
Central venous port-related infection in patients with malignant tumors: an observational study. Ups J Med Sci (2012) 0.75
Application and comparison of different implanted ports in malignant tumor patients. World J Surg Oncol (2016) 0.75
A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute. Int J Clin Oncol (2015) 0.75
Complications after implantation of subcutaneous central venous ports (PowerPort(Ⓡ)). Ann Med Surg (Lond) (2017) 0.75
Brachial insertion of fully implantable venous catheters for chemotherapy: complications and quality of life assessment in 35 patients. Einstein (Sao Paulo) (2017) 0.75
The duration of functioning of a subcutaneous implantable port for the treatment of hematological tumors: a single institution-based study. Int J Clin Oncol (2010) 0.75
Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. Arch Surg (2001) 2.40
Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg (1998) 2.24
Pinch-off syndrome: case report and collective review of the literature. Am Surg (2004) 1.99
Systemic therapy for metastatic colorectal cancer: current options, current evidence. J Clin Oncol (2005) 1.98
Pinch-off syndrome: a complication of implantable subclavian venous access devices. Radiology (1990) 1.83
Peripheral venous access ports: outcomes analysis in 109 patients. Cardiovasc Intervent Radiol (2000) 1.62
Arm placement of the Cook titanium Petite Vital-Port: results of radiologic placement in 125 patients with cancer. Can Assoc Radiol J (2000) 1.60
Placement of long-term central venous catheters in outpatients: study of 134 patients over 24,596 catheter days. AJR Am J Roentgenol (1997) 1.55
Management of venous port systems in oncology: a review of current evidence. Ann Oncol (2007) 1.52
Radiologic placement of subcutaneous infusion chest ports for long-term central venous access. AJR Am J Roentgenol (1997) 1.49
Bedside placement of peripherally inserted central catheters: a cost-effectiveness analysis. Radiology (1998) 1.42
Central venous access ports placed by interventional radiologists: experience with 125 consecutive patients. Cardiovasc Intervent Radiol (2001) 1.30
Outcome of 350 implanted chest ports placed by interventional radiologists. J Vasc Interv Radiol (1998) 1.21
Is radiologic placement of an arm port mandatory in oncology patients?: analysis of a large bi-institutional experience. Cancer (2007) 1.11
Sonographically guided placement of peripherally inserted central venous catheters: review of 355 procedures. AJR Am J Roentgenol (1998) 1.10
Risk of deep venous thrombosis associated with chest versus arm central venous subcutaneous port catheters: a 5-year single-institution retrospective study. J Vasc Interv Radiol (2002) 0.90
Radiology-assisted placement of implantable subcutaneous infusion ports for long-term venous access. Radiology (1992) 0.90
Catheter fracture: a rare complication of totally implantable subclavian venous access devices. J Surg Oncol (1996) 0.90
Peripheral insertion of a central venous access device under fluoroscopic guidance using a peripherally accessed system (PAS) port in the forearm. Cardiovasc Intervent Radiol (1998) 0.84
Experience with the P.A.S.-PORT venous access device in patients with gynecologic malignancies. Gynecol Oncol (1996) 0.81
Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of device. Bone Marrow Transplant (1999) 0.77
Peripheral infusion ports for central venous access in patients with gynecologic malignancies. Gynecol Oncol (1996) 0.75
[Radiologically implanted subcutaneous tunneled central venous catheters for dialysis: the course and complications]. Rofo (1997) 0.75
[Equipment surveillance of implantable catheter ports (1996-1998). Members of Sub-Commissions 4a and 4b for Equipment Surveillance]. Ann Fr Anesth Reanim (2000) 0.75
Long-term outcomes of radiologically placed arm ports. Radiology (1996) 0.75
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol (2011) 5.39
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol (2015) 2.70
Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling. Cancer Cell (2011) 2.45
Evaluation of factors affecting the difficulty of laparoscopic anterior resection for rectal cancer: "narrow pelvis" is not a contraindication. Surg Endosc (2010) 2.37
Strategies to improve clinical research in surgery through international collaboration. Lancet (2013) 2.34
Dclk1 distinguishes between tumor and normal stem cells in the intestine. Nat Genet (2012) 2.33
Crosstalk to stromal fibroblasts induces resistance of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors. Clin Cancer Res (2009) 2.27
Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2015) 2.13
Open versus laparoscopic resection of primary tumor for incurable stage IV colorectal cancer: a large multicenter consecutive patients cohort study. Ann Surg (2012) 2.12
Surgical treatment of congenital coronary artery fistulas: 27 years' experience and a review of the literature. J Card Surg (2002) 1.96
MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem (2010) 1.76
Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination. Gastric Cancer (2006) 1.70
PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome. J Clin Endocrinol Metab (2002) 1.66
Possible link between ulcerative colitis and in situ adenocarcinoma of an appendiceal mucocele: importance of inflammation in the appendiceal orifice related to UC. Inflamm Bowel Dis (2008) 1.59
Total endoscopic robotic atrial septal defect repair in a patient with dextrocardia and situs inversus totalis. Interact Cardiovasc Thorac Surg (2011) 1.57
Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer. Chest (2004) 1.57
Efficacy and safety of on-pump beating heart surgery for valvular disease. Ann Thorac Surg (2002) 1.56
Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene. Cancer Res (2003) 1.53
Premature ovarian failure in a female with proximal symphalangism and Noggin mutation. Fertil Steril (2004) 1.52
Subzero 24-hr nonfreezing rat heart preservation: a novel preservation method in a variable magnetic field. Transplantation (2012) 1.52
Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients. J Clin Endocrinol Metab (2004) 1.51
A novel technique to prevent intra-operative pneumothorax in awake coronary artery bypass grafting: biomaterial neo-pleura. Eur J Cardiothorac Surg (2008) 1.50
Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res (2005) 1.48
Robot-assisted minimally invasive direct coronary artery bypass grafting. ThoraCAB. Circ J (2013) 1.47
Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma. Hepatology (2005) 1.43
Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann Surg Oncol (2009) 1.43
Pathologic and biological assessment of lung tumors showing ground-glass opacity. Ann Thorac Surg (2006) 1.42
Lidocaine-magnesium blood cardioplegia was equivalent to potassium blood cardioplegia in left ventricular function of canine heart. Interact Cardiovasc Thorac Surg (2006) 1.40
Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas. Clin Cancer Res (2005) 1.40
Gastric undifferentiated carcinoma with diffuse c-kit overexpression and focal neuroendocrine differentiation. Pathol Res Pract (2013) 1.40
Usefulness of fluorine-18 fluorodeoxyglucose-positron emission tomography in management strategy for thymic epithelial tumors. Ann Thorac Surg (2012) 1.39
Hybrid surgical angiogenesis: omentopexy can enhance myocardial angiogenesis induced by cell therapy. Ann Thorac Surg (2006) 1.39
Portable coronary active perfusion system for off-pump coronary artery bypass grafting. Ann Thorac Surg (2006) 1.38
Free pericardial fat pads can act as sealant for preventing alveolar air leaks. Ann Thorac Surg (2005) 1.38
Long-term survival cases of lung cancer presented as solitary bone metastasis. Ann Thorac Cardiovasc Surg (2005) 1.37
The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase. Clin Cancer Res (2003) 1.35
Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. Ann Surg Oncol (2009) 1.33
Use of the radial artery graft after transradial catheterization: is it suitable as a bypass conduit? Ann Thorac Surg (2003) 1.31
Medial approach for laparoscopic total gastrectomy with splenic lymph node dissection. J Am Coll Surg (2010) 1.31
Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway. Mol Carcinog (2007) 1.29
Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis (2007) 1.28
Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma. Oncology (2006) 1.28
The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma. Clin Cancer Res (2005) 1.28
Involvement of TSLC1 in progression of esophageal squamous cell carcinoma. Cancer Res (2003) 1.27
Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer. Clin Cancer Res (2010) 1.27
Effectiveness of combined thoracoscopic-laparoscopic esophagectomy: comparison of postoperative complications and midterm oncological outcomes in patients with esophageal cancer. Surg Endosc (2011) 1.25
A library of spirooxindoles based on a stereoselective three-component coupling reaction. J Am Chem Soc (2004) 1.20
Intracorporeal esophagojejunal anastomosis after laparoscopic total gastrectomy for patients with gastric cancer. Surg Endosc (2008) 1.20
Feasibility of laparoscopic gastrectomy with radical lymph node dissection for gastric cancer: from a viewpoint of pancreas-related complications. Surgery (2010) 1.19
Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum. Int J Colorectal Dis (2013) 1.19
The role of CXCR3 and CXCR4 in colorectal cancer metastasis. Int J Cancer (2012) 1.16
Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy. J Clin Oncol (2006) 1.14
Midline prostatic cysts in healthy men: incidence and transabdominal sonographic findings. AJR Am J Roentgenol (2003) 1.14
A biochemically defined system for coding joint formation in V(D)J recombination. Mol Cell (2008) 1.13
Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome. Dis Colon Rectum (2004) 1.12
ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma. Oncology (2007) 1.12
Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Clin Cancer Res (2005) 1.12
Advantage of completely laparoscopic gastrectomy with linear stapled reconstruction: a long-term follow-up study. Ann Surg (2014) 1.12
Laparoscopic versus open intersphincteric resection and coloanal anastomosis for low rectal cancer: intermediate-term oncologic outcomes. Ann Surg (2011) 1.12
Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population. Int J Cancer (2006) 1.11
Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers. Oncology (2005) 1.11
Inferior vena cava occluder for remote access perfusion in robotic cardiac surgery. Minim Invasive Ther Allied Technol (2010) 1.10
Topographic anatomy and laparoscopic technique for dissection of no. 6 infrapyloric lymph nodes in gastric cancer surgery. Gastric Cancer (2013) 1.08
The association between methylenetetrahydrofolate reductase polymorphism and promoter methylation in proximal colon cancer. Anticancer Res (2004) 1.08
The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma. Clin Cancer Res (2007) 1.08
Recurrent yolk sac tumor following resection of a neonatal immature gastric teratoma. Pediatr Surg Int (2005) 1.07
Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles. Int J Oncol (2004) 1.07
Incidence of and risk factors for anastomotic leakage after laparoscopic anterior resection with intracorporeal rectal transection and double-stapling technique anastomosis for rectal cancer. Am J Surg (2011) 1.05
Different histological types of non-small cell lung cancer have distinct folate and DNA methylation levels. Cancer Sci (2009) 1.05
All-trans-retinoic acid prevents radiation- or bleomycin-induced pulmonary fibrosis. Am J Respir Crit Care Med (2006) 1.05
Medially approached radical lymph node dissection along the surgical trunk for advanced right-sided colon cancers. Surg Endosc (2007) 1.04
Molecular and clinical studies in 138 Japanese patients with Silver-Russell syndrome. PLoS One (2013) 1.04
Catalytic asymmetric aldol reactions in aqueous media using chiral bis-pyridino-18-crown-6-rare earth metal triflate complexes. J Am Chem Soc (2003) 1.03
Early outcome of a randomized comparison of off-pump and on-pump multiple arterial coronary revascularization. Circulation (2005) 1.03
Live imaging of protein kinase activities in transgenic mice expressing FRET biosensors. Cell Struct Funct (2012) 1.03
Total Endoscopic Beating-Heart Coronary Artery Bypass Grafting Using A New 3D Imaging System. Innovations (Phila) (2006) 1.03
PGE2 signal through EP2 promotes the growth of articular chondrocytes. J Bone Miner Res (2004) 1.02
Intracranial metastasis from an esophageal gastrointestinal stromal tumor. Intern Med (2010) 1.02